Mineral metabolism parameters throughout chronic kidney disease stages 1-5 -: achievement of K/DOQI target ranges

被引:198
作者
Craver, Lourdes
Paz Marco, Maria
Martinez, Isabel
Rue, Montserrat
Borras, Merce
Luisa Martin, Maria
Sarro, Felipe
Manuel Valdivielso, Jose
Fernandez, Elvira
机构
[1] Hosp Arnau Vilanova, Lleida 25198, Spain
[2] Univ Lleida, Lleida 25198, Spain
[3] Hosp Galdakao, Lleida 25198, Spain
关键词
adequacy; calcium; chronic renal disease; guidelines; hyperparathyroidism; mineral metabolism; parathyroid; phosphate;
D O I
10.1093/ndt/gfl718
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Dialysis Outcomes and Practice Patterns Study has shown that the proportion of haemodialysis patients with adequate mineral metabolism parameters according to the Kidney Disease Outcome Quality Initiative (K/DOQI) guidelines is very low. The adequacy of such parameters in relation to the recommended ranges in patients with different chronic kidney disease (CKD) stages has not been reported. The objective of this study is to provide an in-depth description of mineral metabolism in the early stages of CKD in a European population, and to compare it with current recommendations for stages 3-5 (K/DOQI guidelines). Methods. A total of 1836 patients were classified into stages 1-5 according to K/DOQI guidelines. The following clinical and biochemical data were recorded: age, gender, CKD aetiology, presence of diabetes, serum creatinine, creatinine clearance, serum phosphate, calcium, Ca x P product and intact parathyroid hormone (PTH). Results. A decrease in 1,25-dihydroxyvitamin D and an increase in PTH are the earliest mineral metabolism alterations in CKD, while serum calcium and phosphate are altered later in the course of CKD. The percentages of patients with serum levels within the recommended K/DOQI guidelines for stages 3, 4 and 5 were as follows: serum calcium: 90.7, 85.6 and 55; serum phosphate: 90.9, 77.1 and 70.3; iPTH 42.4, 24.6 and 46.8 and Ca x P product 99.9, 99.6 and 83.8, respectively. The percentages of patients who had all four parameters within the recommended ranges were 34.9, 18.4 and 21.6 for stages 3, 4 and 5, respectively. Conclusion. Mineral metabolism disturbances start early in the course of CKD. The first alterations to take place are a 1,25-dihydroxyvitamin D decrease, a 24 h urine phosphate decrease and a PTH elevation, which show significant level variation when the glomerular filtration rate falls below 60 ml/min. K/DOQI recommended levels for mineral metabolism parameters are difficult to accomplish, in particular for PTH levels.
引用
收藏
页码:1171 / 1176
页数:6
相关论文
共 21 条
[1]  
[Anonymous], 2003, AM J KIDNEY DIS S, V42, pS1
[2]  
[Anonymous], 2002, Am J Kidney Dis
[3]   Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management [J].
Block, GA ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1226-1237
[4]  
CANNATANADIA J, 2000, NEPHROL DIAL TRAN S5, V15
[5]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[6]   Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study [J].
Coen, G ;
Mazzaferro, S ;
Ballanti, P ;
Sardella, D ;
Chicca, S ;
Manni, M ;
Bonucci, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (05) :813-819
[7]  
FOLEY RN, 1998, AM J KIDNEY DIS S3, V32
[8]  
Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131
[9]  
JAMES GH, 1998, J NEPHROL, V11, P203
[10]   Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization [J].
Keith, DS ;
Nichols, GA ;
Gullion, CM ;
Brown, JB ;
Smith, DH .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (06) :659-663